The DOI matches its Crossref record; 12 of the 13 references it cites were found in a registry or an index.
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Open accessPublished version of a preprint
Abstract
Background: The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patients remains largely unknown, and the clinical value of antibody testing has not been fully demonstrated. Methods: 173 patients with SARS-CoV-2 infection were enrolled. Their serial plasma samples (n = 535) collected during hospitalization were tested for total antibodies (Ab), IgM, and IgG against SARS-CoV-2. The dynamics of antibodies with disease progress were analyzed. Results: Among 173 patients, the seroconversion rates for Ab, IgM, and IgG were 93.1%, 82.7%, and 64.7%, respectively. The reason for the negative antibody findings in 12 patients might be due to the lack of blood samples at the later stage of illness. The median seroconversion times for Ab, IgM, and then IgG were days 11, 12, and 4, respectively. The presence of antibodies was <40% among patients within 1 week of onset, and rapidly increased to 100.0% (Ab), 94.3% (IgM), and 79.8% (IgG) by day 15 after onset. In contrast, RNA detectability decreased from 66.7% (58/87) in samples collected before day 7 to 45.5% (25/55) during days 15–39. Combining RNA and antibody detection significantly improved the sensitivity of pathogenic diagnosis for COVID-19 (P < .001), even in the early phase of 1 week from onset (P = .007). Moreover, a higher titer of Ab was independently associated with a worse clinical classification (P = .006). Conclusions: Antibody detection offers vital clinical information during the course of SARS-CoV-2 infection. The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We aligned cases and seroprevalence on the basis of individual record data suggesting that exposure to a laboratory-confirmed case was typically 10–13 days36 and exposure to seroconversion was 14–17 days.37, 38, 39”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M.-X., Liang, L.-J., Huang, H., Hong, Z.-S., Yu, J.-X., Kang, M., Song, Y.-C., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,590
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Yang, Y., Yang, M., Shen, C., Wang, F., Yuan, J., Li, J., Zhang, M., Wang, Z., Xing, L., Wei, J., et al. (2020) · doi:10.1101/2020.02.11.20021493 · Cited by 836
Self-citationLiu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830
Self-citation
Research works printed but not linked: 1
- Guan, Cli, N Engl J Med
Cited by
Sorted by citations
Items 501–600 of 1,003
Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test
Heggestad, J. T., Kinnamon, D., Olson, L. B., Liu, J., Kelly, G., Wall, S. A., Oshabaheebwa, S., Quinn, Z., Fontes, C. M., Joh, D. Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg4901 · Cited by 52
Markmann, A. J., Giallourou, N., Bhowmik, D. R., Hou, Y. J., Lerner, A., Martinez, D. R., Premkumar, L., Root, H. B., van Duin, D., Napravnik, S., et al. (2021) · mSphere · doi:10.1128/msphere.00275-21 · Cited by 54
Yeh, Y., Le, T., Hsiao, W. W., Tung, K., Ostrikov, K., & Chiang, W. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340651 · Cited by 52
Vertical Flow Cellulose-Based Assays for SARS-CoV-2 Antibody Detection in Human Serum
Kim, S., Hao, Y., Miller, E. A., Tay, D. M. Y., Yee, E. H., Kongsuphol, P., Jia, H., McBee, M. E., Preiser, P. R., & Sikes, H. D. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00235 · Cited by 53
Spicuzza, L., Montineri, A., Manuele, R., Crimi, C., Pistorio, M. P., Campisi, R., Vancheri, C., & Crimi, N. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.022 · Cited by 51
Diagnostic efficacy of anti‐SARS‐CoV‐2 IgG/IgM test for COVID‐19: A meta‐analysis
Zhang, Z., Hou, Y., Li, D., & Li, F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26211 · Cited by 50
Self-citationMalfertheiner, S. F., Brandstetter, S., Roth, S., Harner, S., Buntrock‐Döpke, H., Toncheva, A. A., Borchers, N. S., Gruber, R., Ambrosch, A., Kabesch, M., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104575 · Cited by 51
SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review
Grant, R., Dub, T., Andrianou, X. D., Nohynek, H., Wilder‐Smith, A., Pezzotti, P., & Fontanet, A. L. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045425 · Cited by 49
Quashie, P. K., Mutungi, J. K., Dzabeng, F., Oduro‐Mensah, D., Opurum, P. C., Tapela, K., Udoakang, A. J., WACCBIP COVID-19 Team, Asante, I. A., Paemka, L., et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16890.1 · Cited by 47
Jia, R., Wang, X., Liu, P., Liang, X., Ge, Y., Tian, H., Chang, H., Zhou, H., Zeng, M., & Xu, J. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00265-8 · Cited by 50
Self-citationPrazuck, T., Colin, M., Giachè, S., Gubavu, C., Sève, A., Rzepecki, V., Chevereau-Choquet, M., Kiani, C., Rodot, V., Lionnet, E., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237694 · Cited by 50
Methotrexate inhibits SARS‐CoV‐2 virus replication “in vitro”
Caruso, A., Caccuri, F., Bugatti, A., Zani, A., Vanoni, M., Bonfanti, P., Cazzaniga, M. E., Perno, C. F., Messa, C., & Alberghina, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26512 · Cited by 50
SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency
Gupta, S., Su, H., Narsai, T., & Agrawal, S. (2021) · International Archives of Allergy and Immunology · doi:10.1159/000514193 · Cited by 51
Horspool, A. M., Kieffer, T. W., Russ, B. P., DeJong, M. A., Wolf, M. A., Karakiozis, J. M., Hickey, B. J., Fagone, P., Tacker, D. H., Bevere, J. R., et al. (2021) · mSphere · doi:10.1128/msphere.01324-20 · Cited by 48
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
Cyprian, F. S., Sohail, M. U., Abdelhafez, I., Salman, S., Attique, Z., Kamareddine, L., & Al‐Asmakh, M. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.071 · Cited by 50
Sandri, M. T., Azzolini, E., Torri, V., Carloni, S., Pozzi, C., Salvatici, M., Tedeschi, M., Castoldi, M., Mantovani, A., & Rescigno, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91773-4 · Cited by 49
Das, S., Gagandeep, & Bhatia, R. (2022) · Reviews in Analytical Chemistry · doi:10.1515/revac-2022-0037 · Cited by 52
Khan, M. I., & Abbas, Y. M. (2023) · Construction and Building Materials · doi:10.1016/j.conbuildmat.2023.133148 · Cited by 50
Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
Shahrajabian, M. H., Sun, W., & Cheng, Q. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1797369 · Cited by 50
Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls
Premraj, A., Aleyas, A. G., Nautiyal, B., & Rasool, T. J. (2020) · Diagnostics · doi:10.3390/diagnostics10110866 · Cited by 50
Cagigi, A., Yu, M., Österberg, B., Svensson, J., Falck‐Jones, S., Vangeti, S., Åhlberg, E., Azizmohammadi, L., Warnqvist, A., Falck‐Jones, R., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151463 · Cited by 48
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infectionPreprint
Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.18.101717 · Cited by 50
Liu, T., Wu, S., Tao, H., Zeng, G., Zhou, F., Guo, F., & Wang, X. (2020) · medRxiv · doi:10.1101/2020.06.13.20130252 · Cited by 51
Self-citationHarvala, H., Mehew, J., Robb, M. L., Ijaz, S., Dicks, S., Patel, M., Watkins, N. A., Peter Simmonds, K., Brooks, T. J. G., Johnson, R., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.28.2001260 · Cited by 52
Putative Role of Vitamin D for COVID-19 Vaccination
Chiu, S.-K., Tsai, K., Wu, C., Zheng, C., Yang, C., Hu, W., Hou, Y., Lu, K., & Chao, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168988 · Cited by 50
Camerini, D., Randall, A. Z., Trappl, K., Oberai, A., Hung, C., Edgar, J. M., Shandling, A. D., Huynh, V. T., Teng, A., Hermanson, G., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01416-21 · Cited by 50
Johnston, M., Ates, H. C., Glatz, R. T., Mohsenin, H., Schmachtenberg, R., Göppert, N., Huzly, D., Urban, G. A., Weber, W., & Dincer, C. (2022) · Materials Today · doi:10.1016/j.mattod.2022.11.001 · Cited by 50
Pregnancy Outcomes in COVID-19: A Prospective Cohort Study in Singapore
Mattar, C. N. Z., Kalimuddin, S., Sadarangani, S. P., Tagore, S., Thain, S. P. T., Thoon, K. C., Hong, E. Y., Kanneganti, A., Ku, C. W., Chan, G. M., et al. (2020) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2020437 · Cited by 49
Martens, R. J. H., van Adrichem, A. J., Mattheij, N. J. A., Brouwer, C. G., van Twist, D. J. L., Broerse, J. J. C. R., Checa, C. M., van Dongen, C. M. P., Mostard, R. L. M., Ramiro, S., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1529 · Cited by 49
Hsieh, W., Lin, C., Lin, T., Lin, C., Chang, H., Tsai, C.-H., Wu, H., & Lin, C. (2021) · Diagnostics · doi:10.3390/diagnostics11101760 · Cited by 49
The Emerging Role of Convalescent Plasma in the Treatment of COVID‐19
Ψαλτοπούλου, Θ., Sergentanis, T. Ν., Pappa, V., Politou, M., Terpos, E., Tsiodras, S., Pavlakis, G. N., & Dimopoulos, M. A. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000409 · Cited by 48
Liu, R., Liu, X., Li, Y., Han, H. W., Shereen, M. A., Zhen, J., Niu, Z., Li, D., Liu, F., Wu, K., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106746 · Cited by 49
Elucidating reasons of COVID-19 re-infection and its management strategies
Jain, V. K., Iyengar, K. P., Garg, R. K., & Vaishya, R. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.05.008 · Cited by 50
Proposal for the return to routine endoscopy during the COVID-19 pandemic
Gupta, S., Shahidi, N. C., Gilroy, N. M., Rex, D. K., Burgess, N. G., & Bourke, M. J. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.04.050 · Cited by 47
Chen, S., Lee, Y.-L., Lin, Y.-C., Lee, N., Liao, C.-H., Hung, Y., Lu, M., Wu, J.-L., Tseng, W.-P., Lin, C., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1825016 · Cited by 48
Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC
Yoon, H., Bartash, R. M., Gendlina, I., Rivera, J., Nakouzi, A. S., Bortz, R. H., Wirchnianski, A. S., Paroder, M., Fehn, K., Serrano‐Rahman, L., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.142270 · Cited by 46
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients
Schwarz, T., Heiß, K., Mahendran, Y., Casilag, F., Kurth, F., Sander, L. E., Wendtner, C., Hoechstetter, M. A., Müller, M. A., Sekul, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629185 · Cited by 45
Inbaraj, L. R., George, C. E., & Chandrasingh, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249247 · Cited by 47
Plaçais, L., & Richier, Q. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.04.004 · Cited by 47
Giménez, E., Albert, E., Torres, I., Remigia, M. J., Alcaráz, M. J., Galindo, M. J., Blasco, M. L., Solano, C., Forner, M. J., Redón, J., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26213 · Cited by 46
Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19
Ripoll, J. G., van Helmond, N., Senefeld, J. W., Wiggins, C. C., Klassen, S. A., Baker, S. E., Larson, K. F., Murphy, B. M., Andersen, K. J., Ford, S. K., et al. (2021) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2021.02.001 · Cited by 46
Classification Models for COVID-19 Test Prioritization in Brazil: Machine Learning Approach
Santana, Í. V. D. S., da Silveira, A. C. M., Sobrinho, Á., Silva, L. C. E., da Silva, L. D., Santos, D. F. S., Gurjão, E. C., & Perkusich, Â. (2021) · Journal of Medical Internet Research · doi:10.2196/27293 · Cited by 47
Lafon, E., Diem, G., Witting, C., Zaderer, V., Bellmann-Weiler, R. M., Reindl, M., Bauer, A., Griesmacher, A., Fux, V., Hoermann, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684014 · Cited by 46
Tilocca, B., Soggiù, A., Sanguinetti, M., Babini, G., Maio, F. D., Britti, D., Zecconi, A., Bonizzi, L., Urbani, A., & Roncada, P. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.05.013 · Cited by 46
Tang, H., Tian, J.-B., Dong, J.-W., Tang, X.-T., Yan, Z.-Y., Zhao, Y., Xiong, F., Sun, X., Song, C.-X., Xiang, C.-G., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.06.008 · Cited by 46
Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants
Gupta, A. M., Chakrabarti, J., & Mandal, S. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.10.004 · Cited by 45
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
Jaworski, J. P. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.11.011 · Cited by 49
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
Maeda, K., Higashi‐Kuwata, N., Kinoshita, N., Kutsuna, S., Tsuchiya, K., Hattori, S.-I., Matsuda, K., Takamatsu, Y., Gatanaga, H., Oka, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84733-5 · Cited by 44
Alkurt, G., Murt, A., Aydın, Z., Tatlı, Ö., Ağaoğlu, N. B., İrvem, A., Aydın, M., Karaali, R., Güneş, M., Yeşilyurt, B., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247865 · Cited by 46
Back to basics in COVID‐19: Antigens and antibodies—Completing the puzzle
Neagu, M. T., Călina, D. C., Docea, A. O., Constantin, C., Filippini, T., Vinceti, M., Drakoulis, N., Poulas, K. A., Νikolouzakis, Τ. Κ., Spandidos, D. A., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16462 · Cited by 45
Clinical Validity of Serum Antibodies to SARS-CoV-2
Caturegli, G., Materi, J. D., Howard, B. M., & Caturegli, P. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2889 · Cited by 45
Evaluation of serum IgM and IgG antibodies in COVID‐19 patients by enzyme linked immunosorbent assay
Zhou, C. S., Bu, G., Sun, Y. C., Ren, C., Qu, M., Gao, Y., Zhu, Y., Wang, L., Sun, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26741 · Cited by 47
Self-citationAnalysis of viral load in different specimen types and serum antibody levels of COVID-19 patients
Li, L., Tan, C., Zeng, J., Luo, C., Hu, S., Peng, Y., Li, W., Xie, Z., Ling, Y., Zhang, X., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02693-2 · Cited by 46
Ali, M. A., Hu, C., Zhang, F., Jahan, S., Yuan, B., Saleh, M. S., Gao, S., & Panat, R. P. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27591 · Cited by 49
Li, J., Liu, B., Tang, X., Wu, Z., Lu, J., Liang, C., Hou, S., Zhang, L., Li, T., Zhao, W., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.04.042 · Cited by 46
Self-citationBigay, J., Grand, R. L., Martinon, F., & Maisonnasse, P. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.932408 · Cited by 51
Promise and challenges in the development of COVID-19 vaccines
Chen, W. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1787067 · Cited by 47
Yang, H. S., Racine‐Brzostek, S., Lee, W. T., Hunt, D., Yee, J. K., Chen, Z., Kubiak, J. M., Cantu, M. D., Hatem, L., Zhong, E., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.004 · Cited by 46
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
Elshabrawy, H. A. (2020) · Vaccines · doi:10.3390/vaccines8020335 · Cited by 46
Validation and performance comparison of three SARS‐CoV‐2 antibody assays
Paiva, K. J., Grisson, R. D., Chan, P. A., Huard, R. C., Caliendo, A. M., Lonks, J. R., King, E., Tang, E. W., Pytel‐Parenteau, D. L., Nam, G. H., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26341 · Cited by 43
Xu, W., Wang, M., Yu, D., & Zhang, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565278 · Cited by 44
Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic
Schvartz, A., Bélot, A., & Koné‐Paut, I. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.605807 · Cited by 47
Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
Saeedi‐Boroujeni, A., Mahmoudian‐Sani, M., Nashibi, R., Houshmandfar, S., Gandomkari, S. T., & Khodadadi, A. (2021) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2021.1925293 · Cited by 46
COVID-19: systemic pathology and its implications for therapy
Shen, Q., Li, J., Zhang, Z., Guo, S., Wang, Q., An, X., & Chang, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.65911 · Cited by 51
Self-citationHavervall, S., Falk, A. J., Klingström, J., Ng, H., Greilert‐Norin, N., Gabrielsson, L., Salomonsson, A., Isaksson, E., Rudberg, A., Hellström, C., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262169 · Cited by 45
Convalescent plasma for people with COVID-19: a living systematic review
Iannizzi, C., Chai, K. L., Piechotta, V., Valk, S. J., Kimber, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub5 · Cited by 45
COVID-19 : physiopathologie d’une maladie à plusieurs visages
Bonny, V., Maillard, A., Mousseaux, C., Plaçais, L., & Richier, Q. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.05.003 · Cited by 61
Schöler, L., Le‐Trilling, V. T. K., Eilbrecht, M., Mennerich, D., Anastasiou, O. E., Krawczyk, A., Herrmann, A., Dittmer, U., & Trilling, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573526 · Cited by 42
Delshad, M., Tavakolinia, N., Pourbagheri‐Sigaroodi, A., Safaroghli‐Azar, A., Bagheri, N., & Bashash, D. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107586 · Cited by 49
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection
Fröberg, J., & Diavatopoulos, D. A. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000724 · Cited by 45
Management strategies in a SEIR model of COVID 19 community spreadPreprint
Rǎdulescu, A., Williams, C., & Cavanagh, K. (2020) · arXiv (Cornell University) · doi:10.13140/rg.2.2.12643.50726 · Cited by 45
Fu, W., Chen, Q., & Wang, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25968 · Cited by 45
PORTER, J. R., Blau, E. K., Gharagozloo, F., Martino, M. A., Cerfolio, R. J., Duvvuri, U., Caceres, A., Badani, K. K., Bhayani, S. B., Collins, J. W., et al. (2020) · British Journal of Urology · doi:10.1111/bju.15105 · Cited by 44
Shen, Y. H., Anwar, T. B., & Mulchandani, A. (2021) · Sensors and Actuators Reports · doi:10.1016/j.snr.2021.100025 · Cited by 44
Burack, D., Pereira, M. R., Tsapepas, D. S., Harren, P. A., FARR, M. A., Arcasoy, S. M., Cohen, D. J., Mohan, S., Emond, J. C., Hod, E. A., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16541 · Cited by 45
de Perio, M. A., Dowell, C. H., Delaney, L. J., Radonovich, L. J., Kuhar, D. T., Gupta, N., Patel, A., Pillai, S. K., & D’Alessandro, M. (2020) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2020.160 · Cited by 44
Bundschuh, C., Egger, M., Wiesinger, K., Gabriel, C., Clodi, M., Mueller, T., & Dieplinger, B. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.047 · Cited by 44
Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids
Chen, K. G., Park, K., & Spence, J. R. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00721-x · Cited by 45
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections
Luo, J., Brakel, A., Krizsan, A., Ludwig, T., Mötzing, M., Volke, D., Lakowa, N., Grünewald, T., Lehmann, C., Wolf, J., et al. (2022) · Virology Journal · doi:10.1186/s12985-022-01768-4 · Cited by 45
An updated review of SARS‐CoV ‐2 detection methods in the context of a novel coronavirus pandemic
Zhang, Y., Huang, Z., Zhu, J., Li, C., Fang, Z., Chen, K., & Zhang, Y. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10356 · Cited by 45
Shane, A. L., Sato, A. I., Kao, C. M., Adler‐Shohet, F. C., Vora, S. B., Auletta, J. J., Nachman, S., Raabe, V., Inagaki, K., Kalu, I. C., et al. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa099 · Cited by 47
Edouard, S., Colson, P., Melenotte, C., Pinto, F. D., Thomas, L., Scola, B. L., Million, M., Tissot‐Dupont, H., Gautret, P., Stein, A., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04104-2 · Cited by 43
Sandberg, J. T., Varnaitė, R., Christ, W., Chen, P., Muvva, J. R., Maleki, K. T., García, M., Dzidic, M., Folkesson, E., Skagerberg, M., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1306 · Cited by 45
Role of IFN and Complements System: Innate Immunity in SARS-CoV-2
Shibabaw, T., Molla, M. D., Teferi, B., & Ayelign, B. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s267280 · Cited by 51
Greco, R., Alexander, T., Burman, J., Papa, N. D., de Vries‐Bouwstra, J., Farge, D., Henes, J. C., Kazmi, M. A., Киргизов, К. И., Muraro, P. A., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01326-6 · Cited by 44
Olbrich, L., Castelletti, N., Schälte, Y., Garí, M., Pütz, P., Bakuli, A., Pritsch, M., Kroidl, I., Saathoff, E., Noller, J. M. G., et al. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001653 · Cited by 39
Nanomaterials‐based sensors for the detection of COVID‐19: A review
Naikoo, G. A., Arshad, F., Hassan, I. U., Awan, T., Salim, H., Pedram, M. Z., Ahmed, W., Patel, V., Karakoti, A. S., & Vinu, A. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10305 · Cited by 42
Convalescent plasma therapy in patients with COVID ‐19
Yiğenoğlu, T. N., Hacıbekiroğlu, T., Berber, İ., Dal, M. S., Baştürk, A., Namdaroğlu, S., Korkmaz, S., Ulaş, T., Dal, T., Erkurt, M. A., et al. (2020) · Journal of Clinical Apheresis · doi:10.1002/jca.21806 · Cited by 43
Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity
Kong, W., Zhao, R., Zhou, J.-B., Wang, F., Kong, D., Sun, J.-B., Ruan, Q., & Liu, M. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00270-x · Cited by 42
Self-citationKhoshkam, Z., Aftabı, Y., Stenvinkel, P., Lawrence, B. P., Habibi-Rezaei, M., Ichihara, G., & Fereidouni, S. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2020.12.013 · Cited by 45
Green chemistry and coronavirus
Ahmadi, S., Rabiee, N., Fatahi, Y., Hooshmand, S. E., Bagherzadeh, M., Rabiee, M., Jajarmi, V., Dinarvand, R., Habibzadeh, S., Saeb, M. R., et al. (2021) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2021.100415 · Cited by 42
Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection
Гудима, Г. О., Khaitov, R. M., Kudlay, D. A., & Khaitov, M. R. (2021) · Immunologiya · doi:10.33029/0206-4952-2021-42-3-198-210 · Cited by 46
Qasem, A., Shaw, A. M., Elkamel, E., & Naser, S. A. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43020053 · Cited by 43
Deprest, J. A., Choolani, M. A., Chervenak, F. A., Farmer, D. L., Lagrou, K., Lopriore, E., McCullough, L. B., Olutoye, O. A., Simpson, L. L., Mieghem, T. V., et al. (2020) · Fetal Diagnosis and Therapy · doi:10.1159/000508254 · Cited by 42
Suzuki, T., Hayakawa, K., Ainai, A., Iwata‐Yoshikawa, N., Sano, K., Nagata, N., Suzuki, T., Wakimoto, Y., Akiyama, Y., Miyazato, Y., et al. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.09.006 · Cited by 42
Should RT‐PCR be considered a gold standard in the diagnosis of COVID‐19?
Hernández‐Huerta, M. T., Mayoral, L. P.-C., Navarro, L. M. S., Andrade, G. M., Mayoral, E. P., Zenteno, E., & Pérez‐Campos, E. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26228 · Cited by 42
SARS‐CoV‐2 Infection in Health Care Workers: Cross‐sectional Analysis of an Otolaryngology Unit
Paderno, A., Fior, M., Berretti, G., Schreiber, A., Grammatica, A., Mattavelli, D., & Deganello, A. (2020) · Otolaryngology · doi:10.1177/0194599820932162 · Cited by 41
Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge
Papachristodoulou, E., Kakoullis, L., Parperis, K. M., & Panos, G. Z. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa025 · Cited by 43
de Moura, D. T. H., McCarty, T. R., Ribeiro, I. B., Funari, M. P., de Oliveira, P. V. A. G., Neto, A. A. D. M., do Monte, E. S., Tustumi, F., Bernardo, W. M., de Moura, E. G. H., et al. (2020) · Clinics · doi:10.6061/clinics/2020/e2212 · Cited by 42
Zeng, H., Wang, D., Nie, J., Liang, H., Gu, J., Zhao, A., Xu, L., Lang, C., Cui, X., Guo, X., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00329-x · Cited by 41
Self-citation
Metadata
- Authors
- Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., Qian, S., Hong, C., Wang, F., Liu, Y., Wang, Z., He, Q., Li, Z., He, B., Zhang, T., Fu, Y., Ge, S., Liu, L., Zhang, J., Xia, N., & Zhang, Z.
- Affiliations
- Shenzhen Third People’s Hospital (CN)
- Xiamen University (CN)
- Southern University of Science and Technology (CN)
- Corresponding author
- Zhang, Zheng
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-28
- Volume
- 71
- Issue
- 16
- Pages
- 2027-2034
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7184337
- OpenAlex
- W3013985547
- Cited by
- 2,607
- References
- 13
- Citations by year
- 2026: 14 · 2025: 54 · 2024: 95 · 2023: 175 · 2022: 359 · 2021: 862 · 2020: 1046
- FWCI
- 80.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- medRxiv (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bill and Melinda Gates Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, antibody response, seroconversion, IgM, IgG, serological diagnosis, viral RNA detection, disease severity, antibody titers, diagnostic sensitivity
- MeSH terms
- COVID-19, SARS-CoV-2, Adult, Aged, Antibodies, Viral, Antibody Formation, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G, Immunoglobulin M, Male, Middle Aged, Serologic Tests, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
